ECHELONAesthetics Institute Inc
Echelon collection / 29

5-Amino-1MQ

10 mg
Investigational compounds
Product profile

5-Amino-1MQ

The supplied sheet describes 5-Amino-1MQ as an investigational compound associated with NNMT inhibition. It is grouped separately from individual peptide entries.

Composition & presentation

5-Amino-1MQ, 10 mg total, as stated in the heading.

At a glance
Identity5-Amino-1MQ
CategoryInvestigational compounds
Presentation10 mg
AvailabilityNot confirmed by the supplied specification

What to understand

Its inclusion alongside peptides does not define its molecular class or establish a clinical use. A complete technical specification is needed for the exact material.

Listed content and concentrations identify a presentation. They are not a dose, treatment plan or indication of clinical suitability.

Detailed specification tables

Presentation
Stated total content10 mg
Stated container volumeNot confirmed
Label concentrationNot confirmed
Components stated in the supplied sheet
5-Amino-1MQ10 mg

Concentration values are reconciled with the stated total and volume. They are composition details, not a dose or syringe-unit guide.

Topics discussed in the supplied information

The supplied sheet discusses the areas below. They describe the source material’s research or promotional focus and are not verified therapeutic outcomes for this exact preparation.

Source-described areas
NNMT researchThe source discusses NNMT inhibition and NAD+-related pathways.
Metabolic topicsMitochondrial activity and fat-metabolism research appear in the supplied sheet.
Send Inquiry

Ask our team about this product and presentation.

Read the companion article

Recognizing a research compound that is not a peptide. Explore this entry’s identity, how to read its specifications and what documentation to check.

Read the full article